Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa crossover trial of subcutaneous anakinra in adults with cystic fibrosis
2016-004786-80Phase 2Active
- Sponsor
- Heidelberg University
- Start
- Jun 2017
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of anakinra in cystic fibrosis (CF) (2 arms), sponsored by Heidelberg University. Primary endpoint: Absolute pre-post change of the lung clearance index (LCI). Started Jun 2017; status: active.
02
Drugs
anakinra
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2016-004786-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004786-80.